TABLE 3.
Antimicrobial susceptibilities of A. baumannii isolates
| Strain | MIC (mg/liter)a |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TRI | TZP | CRO | FEP | CAZ | IPM | MEM | DOR | ETP | CIP | MXF | AMC | ATM | TGC | DOX | CST | SXT | |
| ATCC 17978 | 8 | 4 | 16 | 4 | 8 | 0.25 | 0.5 | 0.25 | 8 | 0.25 | ≤0.06 | 32 | 16 | 0.12 | ≤0.12 | 2 | 2 |
| AB042 | 256 | 32 | 32 | 8 | 8 | 0.25 | 1 | 0.5 | 16 | 0.5 | 0.25 | 32 | 32 | 0.5 | 0.5 | 2 | 4 |
| AB042/pPLS097 | 256 | ND | ND | ND | ND | ND | ND | ND | ND | 0.5 | 0.125 | ND | ND | ND | ND | ND | ND |
| AB042/pPLS145(adeN) | 256 | ND | ND | ND | ND | ND | ND | ND | ND | 0.25 | ≤0.06 | ND | ND | ND | ND | ND | ND |
| PA006 | 32 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| PA006 plus IPTGs | 64 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| ATCC 17978/pPLS097 | 8 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| ATCC 17978/pPLS151(fabI) | 32 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| ATCC 17978/pPLS150 (fabI116GàV) | >256 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
a
TRI, triclosan; TZP, piperacillin-tazobactam; CRO, ceftriaxone; FEP, cefepime; CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; DOR, doripenem; ETP, ertapenem; CIP, ciprofloxacin; MXF, moxifloxacin; AMC, amoxicillin-clavulanic acid; ATM, aztreonam; TGC, tigecycline; DOX, doxycycline; CST, colistin; SXT, trimethoprim-sulfamethoxazole; IPTG, isopropyl β-D-1-thiogalactopyranoside; ND, not determined.